TerrAscend: Analyst Consensus Estimates For Q3 2021

TerrAscend Corp (CSE: TER) announced that they will be reporting their third quarter financials before the markets open on November 16th.

Analysts have a consensus C$17.96 12-month price target on the company, via a total of 8 analysts, with 3 analysts having strong buy ratings, and the other 5 having buy ratings on the company. The street high comes from Stifel-GMP with an C$23 price target, and the lowest target comes from Needham & Company with a C$13.70 price target.

8 analysts have revenue estimates for the third quarter. The mean between all 8 is US$57.82 million; this number has been revised down from US$80.98 million at the start of May. The street high is US$62 million while the lowest sits at US$54.30 million.

7 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 57.84%, with this number being lower than at the start of May. Street high is 60.70% estimate and the lowest sits at 52%.

Onto EBITDA estimates, there are currently 8 analysts who have third quarter EBITDA estimates. The mean is currently US$19.98 million, with this number has been revised downwards from US$34.01 million at the start of May. Street high sits at US$23.40 million EBITDA and the lowest being a US$15.90 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Red Cloud Fall Mining Showcase 2026 | Day 1

Can an Old Irish Mine Recover the Silver It Left Behind? | Julian Vickers – Northmin Corporation

Is Gold at $4,000 a Buy Zone or a Breakdown? | David Morgan

Recommended

Police Contain ‘Active Threat’ at University of Toronto Mississauga Residence

McLaren Resources Launches Satellite Targeting Program Across Three Timmins Area Gold Properties

Related News

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM

Needham Names Green Thumb Industries, Ayr Strategies As 2021 Top Picks

This month, Needham & Company released a 2021 outlook wherein they named Ayr Strategies (CSE:...

Friday, January 1, 2021, 01:45:00 PM

CloudMD: Canaccord Remains Bullish Following Virtual Conference

Recently, CloudMD Software & Services (TSXV: DOC)‘s CEO Essam Hamza participated in Canaccord Genuity’s Health...

Wednesday, November 25, 2020, 11:11:00 AM

Will The Safe Banking Act Result In Progress For Cannabis? – The Daily Dive feat Jason Wild

Today on the Daily Dive, we get the opportunity to sit down with Jason Wild,...

Thursday, April 29, 2021, 01:30:00 PM

Verano: PI Financial Initiates Coverage With $22 Price Target, Buy Rating

PI Financial last week initiated coverage on Verano Holdings (CSE: VRNO) with a long-term price...

Monday, September 12, 2022, 12:48:59 PM